Characterizing travel burden in oncology clinical trials: A single-institution analysis.
129 Background: Geographic access remains a significant barrier to enrollment of patients (pts) in oncology clinical trials. Previous studies have found that travel burden may disproportionately affect vulnerable racial and ethnic groups and contribute to inequities in trial enrollment (1). This study evaluated...